Spectrophotometric assays in the control of oral anticoagulant therapy by van Dieijen-Visser, M.P. et al.
  
 
Spectrophotometric assays in the control of oral
anticoagulant therapy
Citation for published version (APA):
van Dieijen-Visser, M. P., van Wersch, J., Brombacher, P. J., Rosing, J., Hemker, H. C., & van Dieijen, G.
(1982). Spectrophotometric assays in the control of oral anticoagulant therapy. Haemostasis, 12(1-2),
210. [392]. https://doi.org/10.1159/000317761





Publisher's PDF, also known as Version of record
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.




Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 03 Jun. 2020
:utr
b{a
trh t**.Jb fsroqrag*a e;e--> 4Ut,t+U*lh,:{. *, **a-.a-$
€n^o51fi$\ s l?  { , -e ) ,  e  r* rSsa
yfcTRoFll!,fory?Brc.AssATq_TH fifE egNTnnk CIF on*t iittreoAonrANT rHsrApy:,
1'P, van.Diei jen-vissgpi  r l ,  
""n 
wersei f r" f ; i , - i i rqmrEoler,  J,  Rosing, H.c.  Hemker andG' van Diei ien'  De FeveF Hsepi te l  4eer ie4'"na univ; ; ; i ; i  
" i  i l i * r*rs Maeerr lehr.
were  used  ro  assay  the  c lo i t l ng  feo to rs  I ITV I I , IX  and
and in  p lasma of  98 pat ier rs  reeelv lng longterm
33 normal  subjecrs the in ter - ind iv idual  var ia t lons
cJot t ing factors I I ,  VI I , IX and X ere reepect ive ly
Spectrophotonetric neEhods
X in plasrna of 33 human donors
oral anticoaguLant therapy. In
in the plasma activit ies of the
l l Z ,2 lZ , l 07 .  and  l 52 .
F o r t h e 9 8 p a t i e n t s r e c e i v i n g a n t i c o a g u 1 - a n t t h e r a p y T h r o m b o t e s t v a 1 u e s w e r e c o m p a r e d ,
to  the  ac t iv i t ies  o f  the  v i tamin  K dependent  fac to rs ,  as  assayed w i th  spec t rophoto-  l
met r i c  methods . .  The fac to rs  I I  and X were  assayed w ich  comnerc ia l l y  ava iLab l .e  tes t -
k i ts  (Fac tor  I I ,  Boehr inger  Mannhe im;  Fac tor  X ,Kab i  AB) .
Chromogenic act iv i t ies of the di f ferent factors r^rere correlated among each other and
with I  /Thronnbotest values.
We conclude that factor I I  but also factor X chromogenic act iv i ty in plasma can be
used co uonitor pat ients receiving Longterm ant icoagulant therapy, whereas factor
IX should be preferred to monitor pbt ients reeeiving oral  ant icoagulants during
a shor t  per iod  o f  t ime.
:  = l = -  J  t i  l - : i  : : .  - . ;  : : - r , a s :
' . 9 /  
. i - i  - , J t L : , = : '
: - -  - . . . . - ;  - _ ^ +  : ^ . - 3 . 1 .
r . . a . .  i - . , -  ^ - l - - - ,
r > - - ;  l , / : .  - L . r r -  , D '
-  I . - -
, : { , - - . -  :  . .  -  . ' -
: J : _ ! - . . =  
_  
^ :  
.  . - , : 5
- : . 1 . :
, l  c i  t  a  
-
: ; t  of  i . ' ;  . temr. . t t l . r i r t i . .
' F a c t o r s  I I T V I I T I X , X
: Ant icoagulants
, Chromogenic substrates t2c " 
l__|- 
-ua,i
tr-  - t j -I::,J l is h, ^ : l ^ a . -  - r  -?re t  e r r z l ^ , , - r - - ^ ^ ^ i ^  ^ ^ - ^  . - ^  4 . ^  ^ . - iE r , :  = ;  J  . u t d  l J d t d  i J '  = ; t '  '  r 4 r v ; , J r  i  u r  4 li e : , : , : r . c a  f o r  o r a l  n r e s : n i a i : c i - . 1  _  _  _, - i
l i , ' l i : :g cje Drese:' itacion que oref iere
Pre  i : r r ; t  n : ce  o f  p resen ie . i i on
Or:-t
Oi -a l
*  a : : ct i
l i
; . - ' i : :  
-  
j ;  ( - :  t - u i ' , A l ' l  B L , O u  I j * r . l  t : = l  - C  l - C  , r n l ; :
'  ien i : ' :  r - ic : : i ta iar io  c ie l  l r -aedio: ia ,  Tc. : tc ,  Sp: i i : .
S : .  :  l i c ' i e .  t  , . , : n ,  F ian ;9 . .
I  t '  .  ; :1 ' , : . ;  1 =- : t - i  o n c i  s  r . ;s  ; : *  r :  3 i  c  is ,  ;  I , , ' . ,e s h e d l -  L i  r t  i :  : .1
r - , i .  i : ' r : r i  ' J t ' , ' ' . t ; , i : i . " l o r i d *  i : a s  i : e  E t . .  i : u l i : c  i : - , , ' r i r - c  . l :
' a t '  :  - =
i -  i . -  - / : -  - ^
l : 3 . : .  ; : . .  i , - ,  S - : , r l ; :
i l : d ' - : : . . :  ! c s : ' : . ' t ' .
R. ' -  a  , u '  F rous r .  f , i . - ' ' .
3oston.  USA. ** '  : ie ,? i ta l
- .  
, :  
, . :  : . -  , : l i . : ' . - .  , -  . . .  . .  '  : ,
- . . !  u t  Y : i .
: ,  . , - .  - ,  De Wever -Hosp i ta l
j  
. - :  :3 :  Dept .  o f  C l in ica l
P . 0 .  B d x  4 4 4 5





' - * } - tF  ' - - -
